Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

[1]  P. Liddle,et al.  Brain imaging in schizophrenia , 2007 .

[2]  S. Murphy,et al.  Neuregulin signaling via ErbB receptor assemblies in the nervous system , 2002, Molecular Neurobiology.

[3]  G. Kreutzberg,et al.  Neuregulin-1 isoforms are differentially expressed in the intact and regenerating adult rat nervous system , 2007, Journal of Molecular Neuroscience.

[4]  Richard Coppola,et al.  The G72/G30 Gene Complex and Cognitive Abnormalities in Schizophrenia , 2006, Neuropsychopharmacology.

[5]  S. Whatley,et al.  Mitochondrial involvement in schizophrenia and other functional psychoses , 1996, Neurochemical Research.

[6]  K. Hatanpaa.  The Neuropathology of Dementia, 2nd ed , 2005 .

[7]  Paul J. Harrison,et al.  Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons , 2005, Schizophrenia Research.

[8]  S. Duan,et al.  A family-based study of the association between the G72/G30 genes and schizophrenia in the Chinese population , 2005, Schizophrenia Research.

[9]  A. Grace,et al.  Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia , 2005, Journal of Neural Transmission / General Section JNT.

[10]  H. Beckmann,et al.  Prenatal developmental disturbances in the limbic allocortex in schizophrenics , 2005, Journal of Neural Transmission.

[11]  Paul J. Harrison,et al.  Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain , 2004, Neuroscience.

[12]  C. Austin,et al.  Expression of disrupted-in-schizophrenia-1, a schizophrenia-associated gene, is prominent in the mouse hippocampus throughout brain development , 2004, Neuroscience.

[13]  Chia-Hsiang Chen,et al.  Mutation analysis of the human dystrobrevin-binding protein 1 gene in schizophrenic patients , 2004, Schizophrenia Research.

[14]  W Hennah,et al.  Replication of 1q42 linkage in Finnish schizophrenia pedigrees , 2004, Molecular Psychiatry.

[15]  D. Weinberger,et al.  Genes, dopamine and cortical signal-to-noise ratio in schizophrenia , 2004, Trends in Neurosciences.

[16]  Takahisa Taguchi,et al.  Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. , 2004, Human molecular genetics.

[17]  K. Kendler,et al.  Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families , 2004, Molecular Psychiatry.

[18]  Paul J. Harrison,et al.  Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. , 2004, The American journal of psychiatry.

[19]  R. Gibbs,et al.  Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Neale,et al.  No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF) , 2004, Molecular Psychiatry.

[21]  Paul J. Harrison,et al.  Schizophrenia and its dementia , 2004 .

[22]  H. Stefánsson,et al.  Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype , 2004, Molecular Psychiatry.

[23]  Paul J. Harrison,et al.  Catechol-O-Methyltransferase Inhibition Improves Set-Shifting Performance and Elevates Stimulated Dopamine Release in the Rat Prefrontal Cortex , 2004, The Journal of Neuroscience.

[24]  C. Tamminga,et al.  Regional expression of RGS4 mRNA in human brain † , 2004, The European journal of neuroscience.

[25]  Daniel R Weinberger,et al.  Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. , 2004, Archives of general psychiatry.

[26]  A. Petronis.  The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis , 2004, Biological Psychiatry.

[27]  Deanna Greenstein,et al.  Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified , 2004, Biological Psychiatry.

[28]  Ivan Nikolov,et al.  Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria , 2004, Biological Psychiatry.

[29]  A. Sampson,et al.  Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: Volume, neuron number, and cell types , 2004, The Journal of comparative neurology.

[30]  Raquel E Gur,et al.  Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. , 2004, The Journal of clinical investigation.

[31]  Carmen Birchmeier,et al.  Axonal Neuregulin-1 Regulates Myelin Sheath Thickness , 2004, Science.

[32]  N. Uranova,et al.  Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium , 2004, Schizophrenia Research.

[33]  E. Klein,et al.  Mitochondrial complex i subunits expression is altered in schizophrenia: a postmortem study , 2004, Biological Psychiatry.

[34]  R. Tanzi,et al.  Alzheimer's disease: one disorder, too many genes? , 2004, Human molecular genetics.

[35]  M J Owen,et al.  Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). , 2004, Archives of general psychiatry.

[36]  Victor Vostrikov,et al.  Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. , 2004, The American journal of psychiatry.

[37]  C. Larminie,et al.  Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. , 2004, Brain research. Molecular brain research.

[38]  Huda Akil,et al.  Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. , 2004, Human molecular genetics.

[39]  A. Denman,et al.  Schizophrenia (2nd edn) , 2004, British Journal of Psychiatry.

[40]  K. Yara,et al.  Failure to find association between PRODH deletion and schizophrenia , 2004, Schizophrenia Research.

[41]  S. Faraone,et al.  Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia , 2004, Schizophrenia Research.

[42]  M. Bannon,et al.  Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin , 2004, Journal of neurochemistry.

[43]  R. Kaiser,et al.  Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia , 2004, Psychiatric genetics.

[44]  R Hashimoto,et al.  Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia , 2004, Molecular Psychiatry.

[45]  Michael Gill,et al.  Confirming RGS4 as a susceptibility gene for schizophrenia , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[46]  R. Weinshilboum,et al.  Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes , 2004, Molecular Psychiatry.

[47]  T. Suzuki,et al.  No association with the neuregulin 1 haplotype to Japanese schizophrenia , 2004, Molecular Psychiatry.

[48]  D. Clair,et al.  Confirmation and refinement of an ‘at-risk’ haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus , 2004, Molecular Psychiatry.

[49]  S. Cichon,et al.  Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder , 2004, Molecular Psychiatry.

[50]  Paul J. Harrison,et al.  Catechol‐o‐methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression , 2004, Synapse.

[51]  J. Rain,et al.  Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders , 2004, Molecular and Cellular Neuroscience.

[52]  M. Karayiorgou,et al.  Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia , 2004, Nature Genetics.

[53]  Angus C Nairn,et al.  DARPP-32: an integrator of neurotransmission. , 2004, Annual review of pharmacology and toxicology.

[54]  Michael C O'Donovan,et al.  Support for RGS4 as a susceptibility gene for schizophrenia , 2004, Biological Psychiatry.

[55]  H. Stefánsson,et al.  Neuregulin 1 and schizophrenia , 2004, Annals of medicine.

[56]  George Bartzokis,et al.  Differences between smokers and nonsmokers in regional gray matter volumes and densities , 2004, Biological Psychiatry.

[57]  D. Clair,et al.  A case control and family based association study of the neuregulin1 gene and schizophrenia , 2004, Journal of Medical Genetics.

[58]  T. Crow,et al.  The activities of brain dopamine-β-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls , 1978, Psychopharmacology.

[59]  K. Erlandsson,et al.  Atypical antipsychotics preferentially occupy caudate nucleus D2/D3 receptors within the striatum: A voxel-based analysis , 2004 .

[60]  J. Smythies.  Disorders of synaptic plasticity and schizophrenia , 2004 .

[61]  尾關 祐二.  Disrupted-in-Schizophrenia-1 (DISC-1) : mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth , 2004 .

[62]  W. Honer,et al.  Presynaptic proteins and schizophrenia. , 2004, International review of neurobiology.

[63]  M C O'Donovan,et al.  The molecular genetics of schizophrenia: new findings promise new insights , 2004, Molecular Psychiatry.

[64]  G. He,et al.  Polymorphisms within 5′ end of the Neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population , 2004, Molecular Psychiatry.

[65]  R. Yolken,et al.  Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress , 2004, Molecular Psychiatry.

[66]  T. Kemper,et al.  The neuropathology of the autism spectrum disorders: what have we learned? , 2008, Novartis Foundation symposium.

[67]  Paul J. Harrison.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications , 2004, Psychopharmacology.

[68]  A. Nordberg,et al.  Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease , 2003, Neuroscience.

[69]  Bita Moghaddam,et al.  Bringing Order to the Glutamate Chaos in Schizophrenia , 2003, Neuron.

[70]  M. Owen,et al.  A systematic genomewide linkage study in 353 sib pairs with schizophrenia. , 2003, American journal of human genetics.

[71]  S. Scheff,et al.  Synaptic pathology in Alzheimer’s disease: a review of ultrastructural studies , 2003, Neurobiology of Aging.

[72]  Thomas G Schulze,et al.  The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. , 2003, American journal of human genetics.

[73]  Ethan M. Goldberg,et al.  Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia. , 2003, The American journal of psychiatry.

[74]  W. Honer.  Pathology of presynaptic proteins in Alzheimer’s disease: more than simple loss of terminals , 2003, Neurobiology of Aging.

[75]  M. Egan,et al.  Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. , 2003, The American journal of psychiatry.

[76]  P. Sullivan,et al.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.

[77]  Leena Peltonen,et al.  Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. , 2003, Human molecular genetics.

[78]  Sheila Christie,et al.  Yeast two-hybrid screens implicate DISC1 in brain development and function. , 2003, Biochemical and biophysical research communications.

[79]  P. Mermelstein,et al.  Calcineurin regulation of neuronal plasticity. , 2003, Biochemical and biophysical research communications.

[80]  D. Swallow.  Genetics of lactase persistence and lactose intolerance. , 2003, Annual review of genetics.

[81]  J. Brunet,et al.  Dynamic Expression of RGS4 in the Developing Nervous System and Regulation by the Neural Type-Specific Transcription Factor Phox2b , 2003, The Journal of Neuroscience.

[82]  J. Gault,et al.  Comparison of polymorphisms in the α7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects , 2003 .

[83]  Yusuke Nakamura,et al.  An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis , 2003, Nature Genetics.

[84]  Tao Li,et al.  The genetics of schizophrenia: glutamate not dopamine? , 2003, European journal of pharmacology.

[85]  M. Laruelle,et al.  Glutamate, Dopamine, and Schizophrenia , 2003 .

[86]  Paul J. Harrison,et al.  Meta-analysis of brain weight in schizophrenia , 2003, Schizophrenia Research.

[87]  T. Schneider-Axmann,et al.  Regio entorhinalis in schizophrenia: more evidence for migrational disturbances and suggestions for a new biological hypothesis. , 2003, Pharmacopsychiatry.

[88]  S. Faraone,et al.  Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia , 2003, Molecular Psychiatry.

[89]  J. Kelsoe,et al.  Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. , 2003, Genomics.

[90]  T. Crow,et al.  Size of hippocampal pyramidal neurons in schizophrenia , 2003, British Journal of Psychiatry.

[91]  H. Zoghbi.  Postnatal Neurodevelopmental Disorders: Meeting at the Synapse? , 2003, Science.

[92]  C. Ko,et al.  Glial Cells Maintain Synaptic Structure and Function and Promote Development of the Neuromuscular Junction In Vivo , 2003, Neuron.

[93]  S. Roysommuti,et al.  Neuregulin-1β modulates in vivo entorhinal–hippocampal synaptic transmission in adult rats , 2003, Neuroscience.

[94]  Christopher J. Lee,et al.  Alternative splicing in the nervous system: an emerging source of diversity and regulation , 2003, Biological Psychiatry.

[95]  David B Allison,et al.  "Are we there yet?": Deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits. , 2003, American journal of human genetics.

[96]  Gustavo Turecki,et al.  Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide , 2003, The Journal of Neuroscience.

[97]  A. Simmons,et al.  Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia , 2003, Biological Psychiatry.

[98]  Peter B. Jones,et al.  Oligodendrocyte dysfunction in schizophrenia and bipolar disorder , 2003, The Lancet.

[99]  A. Belger,et al.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development , 2003, Psychopharmacology.

[100]  R. Kahn,et al.  Decreased Thalamic Expression of the Homeobox Gene DLX1 in Psychosis , 2003 .

[101]  R. Coppola,et al.  Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. , 2003, Archives of general psychiatry.

[102]  K. Davis,et al.  Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry. , 2003, Archives of general psychiatry.

[103]  Gareth J Barker,et al.  Gray and white matter brain abnormalities in first-episode schizophrenia inferred from magnetization transfer imaging. , 2003, Archives of general psychiatry.

[104]  Marc Laruelle,et al.  The Synaptic Hypothesis of Schizophrenia , 2003, Neuron.

[105]  Hongkui Zeng,et al.  Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[106]  Susumu Tonegawa,et al.  Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[107]  J. Kim,et al.  The Role of ErbB2 Signaling in the Onset of Terminal Differentiation of Oligodendrocytes In Vivo , 2003, The Journal of Neuroscience.

[108]  G. Kirov,et al.  Detailed analysis of PRODH and PsPRODH reveals no association with schizophrenia , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[109]  David Goldman,et al.  Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing , 2003, Biological Psychiatry.

[110]  Michael C O'Donovan,et al.  A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. , 2003, American journal of human genetics.

[111]  G. Kirov,et al.  Association between PRODH and schizophrenia is not confirmed , 2003, Molecular Psychiatry.

[112]  Christopher P Austin,et al.  DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. , 2003, Human molecular genetics.

[113]  M. Amalric,et al.  Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders , 2003, Behavioural pharmacology.

[114]  Leena Peltonen,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. , 2003, American journal of human genetics.

[115]  D. Talmage,et al.  Back signaling by the Nrg-1 intracellular domain , 2003, The Journal of cell biology.

[116]  W. Ju,et al.  Control of Synaptic Strength, a Novel Function of Akt , 2003, Neuron.

[117]  Patrick R Hof,et al.  Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia , 2003, Biological Psychiatry.

[118]  G. Reynolds,et al.  N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study , 2003, Biological Psychiatry.

[119]  Robert Layfield,et al.  Oligodendrocytes Promote Neuronal Survival and Axonal Length by Distinct Intracellular Mechanisms: A Novel Role for Oligodendrocyte-Derived Glial Cell Line-Derived Neurotrophic Factor , 2003, The Journal of Neuroscience.

[120]  Daniel R Weinberger,et al.  Catechol O-Methyltransferase (COMT) mRNA Expression in the Dorsolateral Prefrontal Cortex of Patients with Schizophrenia , 2003, Neuropsychopharmacology.

[121]  S. Okabe,et al.  The dynamic organization of postsynaptic proteins: translocating molecules regulate synaptic function , 2003, Current Opinion in Neurobiology.

[122]  Y. Fukumaki,et al.  Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia , 2003, Psychiatric genetics.

[123]  Paul J. Harrison,et al.  Low medial and lateral right pulvinar volumes in schizophrenia: a postmortem study. , 2003, The American journal of psychiatry.

[124]  K. Jellinger.  Rett Syndrome – an update , 2003, Journal of Neural Transmission.

[125]  R. Papke,et al.  Nicotinic receptors on local circuit neurons in dentate gyrus: a potential role in regulation of granule cell excitability. , 2003, Journal of neurophysiology.

[126]  C. Austin,et al.  DISC1 (Disrupted in Schizophrenia‐1) is expressed in limbic regions of the primate brain , 2003, Neuroreport.

[127]  Steven G. Potkin,et al.  The neuroanatomy of schizophrenia: circuitry and neurotransmitter systems , 2003, Clinical Neuroscience Research.

[128]  S. Christian,et al.  Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. , 2003, American journal of human genetics.

[129]  M. Owen,et al.  Cis-acting variation in the expression of a high proportion of genes in human brain , 2003, Human Genetics.

[130]  M C O'Donovan,et al.  Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia , 2003, Molecular Psychiatry.

[131]  Philip D. Harvey,et al.  White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.

[132]  M. Egan,et al.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[133]  C. van Broeckhoven,et al.  Alzheimer-associated C allele of the promoter polymorphism -22C>T causes a critical neuron-specific decrease of presenilin 1 expression. , 2003, Human molecular genetics.

[134]  J. Lieberman,et al.  Neurodevelopmental and neurodegenerative hypotheses of schizophrenia: a review and critique , 2003 .

[135]  Peter Falkai,et al.  Volumes of association thalamic nuclei in schizophrenia: a postmortem study , 2003, Schizophrenia Research.

[136]  Paul J. Harrison,et al.  A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia , 2003, Schizophrenia Research.

[137]  M. Gill,et al.  No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study , 2003, Schizophrenia Research.

[138]  Marianna D. Eddy,et al.  Regionally localized thinning of the cerebral cortex in schizophrenia , 2003, Schizophrenia Research.

[139]  B. Kolachana,et al.  Catechol-O-Methyltransferase Genotype and Dopamine Regulation in the Human Brain , 2003, The Journal of Neuroscience.

[140]  Douglas L Falls,et al.  Neuregulins: functions, forms, and signaling strategies. , 2003, Experimental cell research.

[141]  D. Clair,et al.  A family-based association study of T1945C polymorphism in the proline dehydrogenase gene and schizophrenia in the Chinese population , 2003, Neuroscience Letters.

[142]  E. Molnár,et al.  Functional metabotropic glutamate receptors are expressed in oligodendrocyte progenitor cells , 2003, Journal of neurochemistry.

[143]  S. Faraone,et al.  Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. , 2003, The American journal of psychiatry.

[144]  Fu-Chin Liu,et al.  Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences. , 2003, Cerebral cortex.

[145]  David A Lewis,et al.  Reduced Pyramidal Cell Somal Volume in Auditory Association Cortex of Subjects with Schizophrenia , 2003, Neuropsychopharmacology.

[146]  P. Goldman-Rakic,et al.  Up-regulation of the D1 dopamine receptor-interacting protein, calcyon, in patients with schizophrenia. , 2003, Archives of general psychiatry.

[147]  A. Bird,et al.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.

[148]  D. Botstein,et al.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.

[149]  R. Heinrichs,et al.  Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis , 2003, Psychiatry Research: Neuroimaging.

[150]  Stephan Heckers,et al.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. , 2003, Pharmacology & therapeutics.

[151]  Paul J. Harrison,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Genes for Schizophrenia? Recent Findings and Their Pathophysiological Implications , 2022 .

[152]  N. Saitou,et al.  Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. , 2003, Human molecular genetics.

[153]  E. Lander,et al.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.

[154]  John Suckling,et al.  For personal use. Only reproduce with permission from The Lancet Publishing Group. Effect of sunlight and season on serotonin turnover in the brain , 2002 .

[155]  B. Lipska,et al.  Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function , 2003, Neuroscience.

[156]  John M. Lee,et al.  Differences in regional and subcellular localization of Gq/11 and RGS4 protein levels in Alzheimer's disease: Correlation with muscarinic M1 receptor binding parameters , 2003, Synapse.

[157]  Margot Albus,et al.  Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. , 2003, American journal of human genetics.

[158]  Leena Peltonen,et al.  Genetic linkage and association between chromosome 1q and working memory function in schizophrenia , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[159]  J. Gault,et al.  Comparison of polymorphisms in the alpha7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects. , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[160]  M. Laruelle,et al.  Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. , 2003, Annals of the New York Academy of Sciences.

[161]  Kari Stefansson,et al.  Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. , 2003, American journal of human genetics.

[162]  Paul J. Harrison,et al.  Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis , 2003, Molecular Psychiatry.

[163]  Paul J. Harrison,et al.  The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology , 2003, Molecular Psychiatry.

[164]  G. Feng,et al.  Family-based association study of DTNBP1 in 6p22.3 and schizophrenia , 2003, Molecular Psychiatry.

[165]  D. Levinson,et al.  Polymorphisms in the 5′-untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expression , 2003, Molecular Psychiatry.

[166]  P. Sullivan,et al.  Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. , 2003, Molecular Psychiatry.

[167]  H. Hwu,et al.  Linkage of schizophrenia with chromosome 1q loci in Taiwanese families , 2003, Molecular Psychiatry.

[168]  Hongyan Zhang,et al.  Association study of neuregulin 1 gene with schizophrenia , 2003, Molecular Psychiatry.

[169]  M Tohyama,et al.  Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth , 2003, Molecular Psychiatry.

[170]  J. Coyle,et al.  Glutamatergic mechanisms in schizophrenia. , 2003, Annual review of pharmacology and toxicology.

[171]  H. Bock,et al.  Reelin-mediated Signaling Locally Regulates Protein Kinase B/Akt and Glycogen Synthase Kinase 3β* , 2002, The Journal of Biological Chemistry.

[172]  G. Abecasis,et al.  Genetic variation in the 22q11 locus and susceptibility to schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[173]  I. Craig,et al.  Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. , 2002, American journal of medical genetics.

[174]  J. Gault,et al.  Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. , 2002, Archives of general psychiatry.

[175]  K. Kidd,et al.  Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation , 2002, Human Genetics.

[176]  J. Beckmann,et al.  A highly significant association between a COMT haplotype and schizophrenia. , 2002, American journal of human genetics.

[177]  M. Miller,et al.  Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping. , 2002, The American journal of psychiatry.

[178]  D. Shalom.  Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. , 2002 .

[179]  J. Maloteaux,et al.  Opposite modulation of regulators of G protein signalling-2 (RGS2) and RGS4 expression by dopamine receptors in the rat striatum , 2002, Neuroscience Letters.

[180]  S. Robinson,et al.  The amyloid hypothesis: let sleeping dogmas lie? , 2002, Neurobiology of Aging.

[181]  B. Hemmings,et al.  PKB Binding Proteins Getting in on the Akt , 2002, Cell.

[182]  Zheng-Xiong Xi,et al.  The Origin and Neuronal Function of In Vivo Nonsynaptic Glutamate , 2002, The Journal of Neuroscience.

[183]  Steven A. Crone,et al.  Gene Targeting Reveals Multiple Essential Functions of the Neuregulin Signaling System during Development of the Neuroendocrine and Nervous Systems , 2002, Annals of the New York Academy of Sciences.

[184]  J. Lieberman,et al.  Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia , 2002, Biological Psychiatry.

[185]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[186]  D. Campion,et al.  PRODH mutations and hyperprolinemia in a subset of schizophrenic patients. , 2002, Human molecular genetics.

[187]  W. Zago,et al.  Nicotinic α7 Receptor Clusters on Hippocampal GABAergic Neurons: Regulation by Synaptic Activity and Neurotrophins , 2002, The Journal of Neuroscience.

[188]  Nikos Makris,et al.  Left hippocampal volume as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric study of nonpsychotic first-degree relatives. , 2002, Archives of general psychiatry.

[189]  R. Straub,et al.  Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. , 2002, American journal of human genetics.

[190]  Paul Greengard,et al.  Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. , 2002, Archives of general psychiatry.

[191]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[192]  I. Gottesman,et al.  The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia , 2002, BMC psychiatry.

[193]  Paul J. Harrison,et al.  The neuropathology of primary mood disorder. , 2002, Brain : a journal of neurology.

[194]  Daniel R Weinberger,et al.  Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? , 2002, Archives of general psychiatry.

[195]  B. Devlin,et al.  Association and linkage analyses of RGS4 polymorphisms in schizophrenia. , 2002, Human molecular genetics.

[196]  E. Pehek,et al.  Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat , 2002, Brain Research.

[197]  Bita Moghaddam,et al.  Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders , 2002, Biological Psychiatry.

[198]  M. Casanova,et al.  Shape distortion of the hippocampus: a possible explanation of the pyramidal cell disarray reported in schizophrenia , 2002, Schizophrenia Research.

[199]  T. Crow,et al.  Estimated neuronal populations and volumes of the hippocampus and its subfields in schizophrenia. , 2002, The American journal of psychiatry.

[200]  C. Beasley,et al.  Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neurons , 2002, Journal of Neural Transmission.

[201]  John Stewart,et al.  A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. , 2002, The American journal of psychiatry.

[202]  Sabine Landau,et al.  Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. , 2002, Cerebral cortex.

[203]  A. Malhotra,et al.  A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. , 2002, The American journal of psychiatry.

[204]  Ellen M Wijsman,et al.  Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[205]  K. Murphy,et al.  Schizophrenia and velo-cardio-facial syndrome , 2002, The Lancet.

[206]  R. Belmaker,et al.  GSK-3 and the neurodevelopmental hypothesis of schizophrenia , 2002, European Neuropsychopharmacology.

[207]  Diano F. Marrone,et al.  The role of synaptic morphology in neural plasticity: structural interactions underlying synaptic power , 2002, Brain Research Reviews.

[208]  David A Lewis,et al.  The Human Brain Revisited: Opportunities and Challenges in Postmortem Studies of Psychiatric Disorders , 2002, Neuropsychopharmacology.

[209]  R. Wise,et al.  Dopamine Uptake through the Norepinephrine Transporter in Brain Regions with Low Levels of the Dopamine Transporter: Evidence from Knock-Out Mouse Lines , 2002, The Journal of Neuroscience.

[210]  S. Cichon,et al.  Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population. , 2002, American journal of medical genetics.

[211]  M. Karayiorgou,et al.  Brain catecholamine metabolism in catechol‐O‐methyltransferase (COMT)‐deficient mice , 2002, The European journal of neuroscience.

[212]  H. Schiffer.  Glutamate receptor genes: susceptibility factors in schizophrenia and depressive disorders? , 2002, Molecular neurobiology.

[213]  William Byne,et al.  Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. , 2002, The American journal of psychiatry.

[214]  R. Martins,et al.  Variation at the APOE −491 promoter locus is associated with altered brain levels of apolipoprotein E , 2002, Molecular Psychiatry.

[215]  C. Stefanis,et al.  Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele , 2002, Molecular Psychiatry.

[216]  C. Beasley,et al.  Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depressive disorder: no evidence for abnormalities of neuronal migration , 2002, Molecular Psychiatry.

[217]  J. Kleinman,et al.  Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects , 2002, Molecular Psychiatry.

[218]  B. Madras,et al.  Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression , 2002, Molecular Psychiatry.

[219]  E. Gershon,et al.  Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia , 2002, Molecular Psychiatry.

[220]  P. Sham,et al.  Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. , 2002, Nature Reviews Genetics.

[221]  Daniel R. Weinberger,et al.  Prefrontal neurons and the genetics of schizophrenia , 2001, Biological Psychiatry.

[222]  J. Gault,et al.  Smoking and mental illness , 2001, Pharmacology Biochemistry and Behavior.

[223]  S. Heckers,et al.  Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia , 2001, Biological Psychiatry.

[224]  P. Greengard.  The neurobiology of slow synaptic transmission. , 2001, Science.

[225]  P. Robinson,et al.  The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis , 2001, Trends in Neurosciences.

[226]  A. Fine,et al.  Ultrastructural Distribution of the α7 Nicotinic Acetylcholine Receptor Subunit in Rat Hippocampus , 2001, The Journal of Neuroscience.

[227]  Paul J. Harrison,et al.  Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia , 2001, Hippocampus.

[228]  R. Greene.  Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia † , 2001, Hippocampus.

[229]  A. Guidotti,et al.  Dendritic Spine Hypoplasticity and Downregulation of Reelin and GABAergic Tone in Schizophrenia Vulnerability , 2001, Neurobiology of Disease.

[230]  S. Heckers,et al.  Neuroimaging studies of the hippocampus in schizophrenia , 2001, Hippocampus.

[231]  R. Shigemoto,et al.  Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites , 2001, Neuroscience.

[232]  Pat Levitt,et al.  Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse , 2001, Trends in Neurosciences.

[233]  D J Porteous,et al.  Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. , 2001, American journal of human genetics.

[234]  Paul J. Harrison,et al.  Cerebellar synaptic protein expression in schizophrenia , 2001, Neuroscience.

[235]  J S Sinsheimer,et al.  Chromosome 1 loci in Finnish schizophrenia families. , 2001, Human molecular genetics.

[236]  N. Uranova,et al.  Electron microscopy of oligodendroglia in severe mental illness , 2001, Brain Research Bulletin.

[237]  Mary Johnson,et al.  Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia , 2001, Journal of Chemical Neuroanatomy.

[238]  J. David Sweatt,et al.  Roles of serine/threonine phosphatases in hippocampel synaptic plasticity , 2001, Nature Reviews Neuroscience.

[239]  D. Blake,et al.  Dysbindin, a Novel Coiled-coil-containing Protein That Interacts with the Dystrobrevins in Muscle and Brain* , 2001, The Journal of Biological Chemistry.

[240]  G. Fischbach,et al.  Neuregulin and ErbB receptor signaling pathways in the nervous system , 2001, Current Opinion in Neurobiology.

[241]  D. Blackwood,et al.  Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder , 2001, Psychiatric genetics.

[242]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[243]  A. Sampson,et al.  Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. , 2001, Archives of general psychiatry.

[244]  D. Lewis,et al.  Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.

[245]  R. McCarley,et al.  A review of MRI findings in schizophrenia , 2001, Schizophrenia Research.

[246]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[247]  M. Ozaki.  Neuregulins and the Shaping of Synapses , 2001, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[248]  A. Sampson,et al.  Dopamine transporter immunoreactivity in monkey cerebral cortex: Regional, laminar, and ultrastructural localization , 2001, The Journal of comparative neurology.

[249]  P. Lantos,et al.  The Neuropathology of Schizophrenia. Progress and Interpretation , 2001 .

[250]  F. Nicoletti,et al.  Molecular determinants of metabotropic glutamate receptor signaling. , 2001, Trends in pharmacological sciences.

[251]  T. Sigmundsson,et al.  Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. , 2001, The American journal of psychiatry.

[252]  L. Friedman,et al.  Meta-analysis of thalamic size in schizophrenia , 2001, Biological Psychiatry.

[253]  B. Mowry,et al.  Molecular genetics of schizophrenia. , 2001, Clinical and experimental pharmacology & physiology.

[254]  R. Freedman,et al.  The α7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia , 2000, Journal of Chemical Neuroanatomy.

[255]  Yogesh K. Dwivedi,et al.  Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. , 2000, Archives of general psychiatry.

[256]  K. Weiss,et al.  How many diseases does it take to map a gene with SNPs? , 2000, Nature Genetics.

[257]  R. Roth,et al.  Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization. , 2000, The Journal of pharmacology and experimental therapeutics.

[258]  A. Wolffe,et al.  DNA methylation in health and disease , 2000, Nature Reviews Genetics.

[259]  Pat Levitt,et al.  Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.

[260]  D. Schoepp,et al.  Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors , 2000, Journal of neurochemistry.

[261]  J. Neale,et al.  N‐Acetylaspartylglutamate , 2000, Journal of neurochemistry.

[262]  E G Jones,et al.  Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[263]  David A Lewis,et al.  Intrinsic excitatory connections in the prefrontal cortex and the pathophysiology of schizophrenia , 2000, Brain Research Bulletin.

[264]  D. Porteous,et al.  Chromosomal location and genomic structure of the human translin-associated factor X gene (TRAX; TSNAX) revealed by intergenic splicing to DISC1, a gene disrupted by a translocation segregating with schizophrenia. , 2000, Genomics.

[265]  R. Murray,et al.  Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11 , 2000, Molecular Psychiatry.

[266]  S. Grant,et al.  Proteomic analysis of NMDA receptor–adhesion protein signaling complexes , 2000, Nature Neuroscience.

[267]  R. Hoffman,et al.  Schizophrenia as a disorder of developmentally reduced synaptic connectivity. , 2000, Archives of general psychiatry.

[268]  D. German,et al.  Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia , 2000, Biological Psychiatry.

[269]  T. Schneider-Axmann,et al.  Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality , 2000, Biological Psychiatry.

[270]  Martin S. Taylor,et al.  Disruption of two novel genes by a translocation co-segregating with schizophrenia. , 2000, Human molecular genetics.

[271]  R. Gerlai,et al.  Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks , 2000, Behavioural Brain Research.

[272]  Agneta Nordberg,et al.  Neuronal nicotinic receptors in the human brain , 2000, Progress in Neurobiology.

[273]  W. Honer,et al.  Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. , 2000, Science.

[274]  D. Linden,et al.  D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[275]  G. Rosoklija,et al.  Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. , 2000, Archives of general psychiatry.

[276]  M. Mehler.  Brain dystrophin, neurogenetics and mental retardation , 2000, Brain Research Reviews.

[277]  D. Lewis.  GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia , 2000, Brain Research Reviews.

[278]  I. Gottesman,et al.  Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. , 2000, American journal of medical genetics.

[279]  F. Benes,et al.  Emerging principles of altered neural circuitry in schizophrenia , 2000, Brain Research Reviews.

[280]  R S Kahn,et al.  Structural brain abnormalities in patients with schizophrenia and their healthy siblings. , 2000, The American journal of psychiatry.

[281]  K. Davis,et al.  Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus , 2000, Biological Psychiatry.

[282]  P. McKenna,et al.  A sceptical view of the neuropathology of schizophrenia , 2000 .

[283]  M. Farquhar,et al.  The regulator of G protein signaling family. , 2000, Annual review of pharmacology and toxicology.

[284]  R. Murray,et al.  Meta-analysis of regional brain volumes in schizophrenia. , 2000, The American journal of psychiatry.

[285]  K. Vogeley,et al.  Disturbed gyrification of the prefrontal region in male schizophrenic patients: A morphometric postmortem study. , 2000, The American journal of psychiatry.

[286]  E M Ross,et al.  GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. , 2000, Annual review of biochemistry.

[287]  D. Lewis,et al.  Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. , 2000, Archives of general psychiatry.

[288]  H. Yeh,et al.  Neuregulin Induces GABAA Receptor Subunit Expression and Neurite Outgrowth in Cerebellar Granule Cells , 1999, The Journal of Neuroscience.

[289]  P. Männistö,et al.  Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. , 1999, Pharmacological reviews.

[290]  Paul J. Harrison.  The neuropathological effects of antipsychotic drugs , 1999, Schizophrenia Research.

[291]  Lynn E. DeLisi,et al.  Defining the course of brain structural change and plasticity in schizophrenia , 1999, Psychiatry Research: Neuroimaging.

[292]  B. Kirkpatrick,et al.  Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: An unbiased cell‐counting study , 1999, Synapse.

[293]  K. Jellinger,et al.  The neuropathology of schizophrenia. , 1999, Journal of neuropathology and experimental neurology.

[294]  R. Kerwin,et al.  Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia , 1999, Journal of neurochemistry.

[295]  A. Sampson,et al.  Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. , 1999, The American journal of psychiatry.

[296]  B. Turetsky,et al.  Reduced gray matter volume in schizophrenia. , 1999, Archives of general psychiatry.

[297]  Godfrey D Pearlson,et al.  Structural brain imaging in schizophrenia: a selective review , 1999, Biological Psychiatry.

[298]  N. Andreasen.  A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly. , 1999, Archives of general psychiatry.

[299]  Kenneth K Kidd,et al.  Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles , 1999, Biological Psychiatry.

[300]  J. Seamans,et al.  Developing a Neuronal Model for the Pathophysiology of Schizophrenia Based on the Nature of Electrophysiological Actions of Dopamine in the Prefrontal Cortex , 1999, Neuropsychopharmacology.

[301]  J. Basilion,et al.  Single-nucleotide polymorphisms can cause different structural folds of mRNA. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[302]  S. Ho,et al.  Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. , 1999, Molecular pharmacology.

[303]  Max A Viergever,et al.  Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology , 1999, Biological Psychiatry.

[304]  K. Blennow,et al.  Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. , 1999, Neuroreport.

[305]  A Bertolino,et al.  Proton magnetic resonance spectroscopy in schizophrenia. , 1999, European journal of radiology.

[306]  M. Karayiorgou,et al.  The gene encoding proline dehydrogenase modulates sensorimotor gating in mice , 1999, Nature Genetics.

[307]  Paul J. Harrison.  The neuropathology of schizophrenia , 2008 .

[308]  R. Nardacci,et al.  Immunocytochemical localization of d-amino acid oxidase in rat brain , 1999, Journal of neurocytology.

[309]  K. Jellinger,et al.  No increased incidence of Alzheimer’s disease in elderly schizophrenics , 1999, Acta Neuropathologica.

[310]  Eve C Johnstone,et al.  Magnetic resonance imaging of brain in people at high risk of developing schizophrenia , 1999, The Lancet.

[311]  Paul J. Harrison.  Brains at risk of schizophrenia , 1999, The Lancet.

[312]  R. Roberts,et al.  Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study , 1999 .

[313]  P. Goldman-Rakic,et al.  The reduced neuropil hypothesis: a circuit based model of schizophrenia , 1999, Biological Psychiatry.

[314]  R. Weinshilboum,et al.  Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. , 1999, Annual review of pharmacology and toxicology.

[315]  Paul J. Harrison,et al.  Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia , 1998, The Lancet.

[316]  S. Hirsch,et al.  Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia , 1998, Journal of neurology, neurosurgery, and psychiatry.

[317]  C. Stefanis,et al.  Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21 , 1998, Nature Genetics.

[318]  B. Moghaddam,et al.  Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. , 1998, Science.

[319]  J Hong,et al.  Distribution of catechol‐O‐methyltransferase expression in human central nervous system , 1998, Neuroreport.

[320]  D. Pfaff,et al.  Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[321]  Lina Shihabuddin,et al.  Ventricular Enlargement in Poor-Outcome Schizophrenia , 1998, Biological Psychiatry.

[322]  D J Mikulis,et al.  Cerebral gray matter volume deficits in first episode psychosis. , 1998, Archives of general psychiatry.

[323]  Michael D. Nelson,et al.  Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging : A meta-analytic study , 1998 .

[324]  P. McKenna,et al.  Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. , 1998, Brain research. Molecular brain research.

[325]  Alessandro Bertolino,et al.  Regionally Specific Neuronal Pathology in Untreated Patients with Schizophrenia: A Proton Magnetic Resonance Spectroscopic Imaging Study , 1998, Biological Psychiatry.

[326]  Allan I. Levey,et al.  Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter , 1998, The Journal of Neuroscience.

[327]  I. Módy,et al.  The absence of a major Ca2+ signaling pathway in GABAergic neurons of the hippocampus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[328]  P. Goldman-Rakic,et al.  Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. , 1998, Archives of general psychiatry.

[329]  J. Trojanowski,et al.  Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. , 1998, Archives of general psychiatry.

[330]  S. Lawrie,et al.  Brain abnormality in schizophrenia , 1998, British Journal of Psychiatry.

[331]  L. Role,et al.  A Cysteine-Rich Isoform of Neuregulin Controls the Level of Expression of Neuronal Nicotinic Receptor Channels during Synaptogenesis , 1998, Neuron.

[332]  K. Davies,et al.  beta-dystrobrevin, a member of the dystrophin-related protein family. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[333]  C. Tamminga,et al.  Schizophrenia and glutamatergic transmission. , 1998, Critical reviews in neurobiology.

[334]  R. Saunders,et al.  A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. , 1997, Cerebral cortex.

[335]  Robert Freedman,et al.  Comparison of the regional expression of nicotinic acetylcholine receptor α7 mRNA and [125I]‐α‐bungarotoxin binding in human postmortem brain , 1997 .

[336]  R. Murray,et al.  Catechol‐O‐methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families , 1997, Psychiatric genetics.

[337]  J. Nadler,et al.  Proline-induced inhibition of glutamate release in hippocampal area CA1 , 1997, Brain Research.

[338]  M. Akil,et al.  Cytoarchitecture of the entorhinal cortex in schizophrenia. , 1997, The American journal of psychiatry.

[339]  Paul J. Harrison,et al.  Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia. , 1997, The American journal of psychiatry.

[340]  F. Benes,et al.  Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia. , 1997, The American journal of psychiatry.

[341]  Douglas W. Jones,et al.  Cortical abnormality in schizophrenia: An in vivo application of the gyrification index , 1997, Biological Psychiatry.

[342]  Paul J. Harrison.  Schizophrenia: a disorder of neurodevelopment? , 1997, Current Opinion in Neurobiology.

[343]  L Kruglyak,et al.  Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[344]  R Freedman,et al.  Comparison of the regional expression of nicotinic acetylcholine receptor alpha7 mRNA and [125I]-alpha-bungarotoxin binding in human postmortem brain. , 1997, The Journal of comparative neurology.

[345]  J. Tenhunen,et al.  Expression and intracellular localization of catechol O-methyltransferase in transfected mammalian cells. , 1997, European journal of biochemistry.

[346]  R. Weinshilboum,et al.  Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.

[347]  E. G. Jones,et al.  Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. , 1996, Archives of general psychiatry.

[348]  D. Volk,et al.  Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects , 1996, Schizophrenia Research.

[349]  P. Emson,et al.  Molecular characterization and localization of human metabotropic glutamate receptor type 3. , 1996, Brain research. Molecular brain research.

[350]  R. Petralia,et al.  The metabotropic glutamate receptors, MGLUR2 and MGLUR3, show unique postsynaptic, presynaptic and glial localizations , 1996, Neuroscience.

[351]  R. Murray,et al.  Preferential transmission of the high activity allele of COMT in schizophrenia , 1996, Psychiatric genetics.

[352]  U. Rüb,et al.  Variability in the human entorhinal region may confound neuropsychiatric diagnoses. , 1996, Acta anatomica.

[353]  J. Trojanowski,et al.  Cognitive impairment in elderly schizophrenia: a dementia (still) lacking distinctive histopathology. , 1996, Schizophrenia bulletin.

[354]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[355]  Paul J. Harrison,et al.  The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins , 1995, Neuroscience Letters.

[356]  R. Straub,et al.  A potential vulnerability locus for schizophrenia on chromosome 6p24–22: evidence for genetic heterogeneity , 1995, Nature Genetics.

[357]  D. Weinberger,et al.  From neuropathology to neurodevelopment , 1995, The Lancet.

[358]  R. Freedman,et al.  Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia , 1995, Biological Psychiatry.

[359]  J. Trojanowski,et al.  Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. , 1995, The American journal of psychiatry.

[360]  I. Ulmanen,et al.  Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.

[361]  Karl J. Friston,et al.  Schizophrenia: a disconnection syndrome? , 1995, Clinical neuroscience.

[362]  E. Hirsch,et al.  Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system , 1994, Neuroscience.

[363]  T. Kiviluoto,et al.  Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. , 1994, European journal of biochemistry.

[364]  M. Owen,et al.  The molecular genetics of schizophrenia. , 1992, Neuropathology and applied neurobiology.

[365]  B. Pakkenberg,et al.  Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors , 1993, Biological Psychiatry.

[366]  S. Nakanishi,et al.  Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: An in situ hybridization study , 1993, The Journal of comparative neurology.

[367]  Paul J. Harrison,et al.  Pre‐and Postmortem Influences on Brain RNA , 1993, Journal of neurochemistry.

[368]  J J Kim,et al.  Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. , 1993, Archives of general psychiatry.

[369]  C A Sandman,et al.  Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. , 1993, Archives of general psychiatry.

[370]  D. Weinberger,et al.  Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. , 1992, The American journal of psychiatry.

[371]  T M Hyde,et al.  Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. , 1992, Archives of neurology.

[372]  J Q Trojanowski,et al.  Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[373]  S. Heckers,et al.  Hippocampal neuron number in schizophrenia. A stereological study. , 1991, Archives of general psychiatry.

[374]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[375]  B T Hyman,et al.  Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. , 1991, Archives of general psychiatry.

[376]  J. Hardy,et al.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.

[377]  F. Benes,et al.  Reduced neuronal size in posterior hippocampus of schizophrenic patients. , 1991, Schizophrenia bulletin.

[378]  B. Pakkenberg,et al.  Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. , 1990, Archives of general psychiatry.

[379]  M. Ron,et al.  The brain in schizophrenia. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[380]  D. Clair,et al.  Association within a family of a balanced autosomal translocation with major mental illness , 1990, The Lancet.

[381]  A. Carlsson,et al.  Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease , 1990, Trends in Neurosciences.

[382]  G. Roberts,et al.  Schizophrenia: the cellular biology of a functional psychosis , 1990, Trends in Neurosciences.

[383]  T. Crow,et al.  Schizophrenia and the brain: a prospective clinico-neuropathological study , 1990, Psychological Medicine.

[384]  N. Risch.  Linkage strategies for genetically complex traits. II. The power of affected relative pairs. , 1990, American journal of human genetics.

[385]  T. Crow,et al.  Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. , 1989, Archives of general psychiatry.

[386]  S. Siris,et al.  Implications of normal brain development for the pathogenesis of schizophrenia. , 1988, Archives of general psychiatry.

[387]  A. Labbé,et al.  Isolated familial adrenocorticotropin deficiency: prenatal diagnosis by maternal plasma estriol assay. , 1988, American journal of medical genetics.

[388]  E. Roberts,et al.  Proline, glutamate and glutamine metabolism in mouse brain synaptosomes , 1984, Brain Research.

[389]  R J Wyatt,et al.  Schizophrenia: evidence of a subgroup with reversed cerebral asymmetry. , 1979, Archives of general psychiatry.

[390]  R. Weinshilboum,et al.  Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. , 1977, American journal of human genetics.

[391]  J. Shields,et al.  A polygenic theory of schizophrenia. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[392]  J. Axelrod,et al.  O-Methylation of catechol amines in vivo. , 1958, The Journal of biological chemistry.

[393]  J. Axelrod,et al.  Enzymatic O-methylation of epinephrine and other catechols. , 1958, The Journal of biological chemistry.